Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy. [electronic resource]
Producer: 20160929Description: 329-34 p. digitalISSN:- 1879-3320
- Adenocarcinoma -- drug therapy
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Carcinoma, Adenosquamous -- drug therapy
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Chemoradiotherapy
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Female
- Follow-Up Studies
- Humans
- Immunoenzyme Techniques
- Inhibitor of Apoptosis Proteins -- metabolism
- Lung Neoplasms -- drug therapy
- Lymph Node Excision
- Male
- Middle Aged
- Neoplasm Invasiveness
- Neoplasm Recurrence, Local -- pathology
- Neoplasm Staging
- Paclitaxel -- administration & dosage
- Prognosis
- Retrospective Studies
- Survival Rate
- Survivin
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.